Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
$5.63M
Mr. Jeffrey F. Eisenberg Esq.
4.00
Framingham, MA
Nov 07, 2016
-1.19
$-3.06
12.31
13.82
-184.97%
-1.23
0.41
2.28
12.31
-31.31%
-30.18%
Similar stocks (13)
Immix Biopharma, Inc.
IMMX
GeoVax Labs, Inc.
GOVX
Tonix Pharmaceuticals Holding Corp.
TNXP
TransCode Therapeutics, Inc.
RNAZ
Sonnet BioTherapeutics Holdings, Inc.
SONN
Palisade Bio, Inc.
PALI
Enveric Biosciences, Inc.
ENVB
Phio Pharmaceuticals Corp.
PHIO
NovaBay Pharmaceuticals, Inc.
NBY
180 Life Sciences Corp.
ATNF
Revelation Biosciences, Inc.
REVB
NexImmune, Inc.
NEXI
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
Immix Biopharma, Inc.
IMMX
GeoVax Labs, Inc.
GOVX
Tonix Pharmaceuticals Holding Corp.
TNXP
TransCode Therapeutics, Inc.
RNAZ
Sonnet BioTherapeutics Holdings, Inc.
SONN
Palisade Bio, Inc.
PALI
Enveric Biosciences, Inc.
ENVB
Phio Pharmaceuticals Corp.
PHIO
NovaBay Pharmaceuticals, Inc.
NBY
180 Life Sciences Corp.
ATNF
Revelation Biosciences, Inc.
REVB
NexImmune, Inc.
NEXI
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%